ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 178 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
| RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
| Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
| ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
| New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
| MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
| Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
| Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
| Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
| Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |
| COWEN AND COMPANY, LLC | 1,100,000 | $22,539,000 | 1.58% |
| Novo Holdings A/S | 1,001,000 | $20,510,490 | 1.52% |
| Avidity Partners Management LP | 1,587,429 | $32,526,420 | 1.31% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 156,000 | $3,193,320 | 1.08% |
| Perceptive Advisors | 1,517,467 | $31,092,899 | 1.04% |
| SECTORAL ASSET MANAGEMENT INC | 227,030 | $4,651,845 | 0.91% |
| Privium Fund Management B.V. | 143,350 | $2,937,242 | 0.87% |
| SPHERA FUNDS MANAGEMENT LTD. | 209,040 | $4,283,230 | 0.78% |
| EFG Asset Management (North America) Corp. | 151,068 | $3,093,873 | 0.74% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 4,193,996 | $85,934,978 | 0.58% |
External links
This page lists ROCKET PHARMACEUTICALS INC's shareholders in Q3 2023. To view ROCKET PHARMACEUTICALS INC's shareholder history, click here.